Reproducibility of Cirrus Optical Coherence Tomography Measurements

July 21, 2008 updated by: The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery

Reproducibility of Retinal Thickness and Volume Measurements Determined With the Cirrus Spectral Domain OCT

In this study the reproducibility of optical coherence tomography measurements should be evaluated.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Anticipated)

16

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Austria
      • Vienna, Austria, 1030
        • Rudolf Foundation Clinic

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

attendants of health care center

Description

Inclusion Criteria:

  • 18 years of age or older
  • best corrected visual acuity of at least 20/25
  • clear optical media

Exclusion Criteria:

  • any kind of retinal pathology
  • any kind of opacity of optical media
  • any kind of intraocular surgery
  • spherical refraction of more than 5 diopters
  • cylindrical refraction of more than 3 diopters
  • amblyopia

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Observation
Device: Cirrus™ HD-OCT, Carl Zeiss Meditec AG
the retinal thickness and volume is determined on two different days with the Cirrus™ HD-OCT.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
retinal thickness
Time Frame: two
two

Secondary Outcome Measures

Outcome Measure
Time Frame
retinal volume
Time Frame: two
two

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

First Submitted

March 22, 2008

First Submitted That Met QC Criteria

March 25, 2008

First Posted (Estimate)

March 26, 2008

Study Record Updates

Last Update Posted (Estimate)

July 22, 2008

Last Update Submitted That Met QC Criteria

July 21, 2008

Last Verified

July 1, 2008

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • Cirrus_OCT_0308

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on Cirrus™ HD-OCT, Carl Zeiss Meditec AG

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Hungary

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe